Brainomix Achievements in 2024
Brainomix, a leader in artificial intelligence imaging solutions, has recently received significant accolades including the LSX European Lifestars Award for “Healthtech Company of the Year” and the “Most Transformative Healthtech Company of the Year” by OBN. These awards underscore the impact of their software on treatment rates and patient care.
The Impact of AI in Healthcare
The recognition of Brainomix reflects its substantial success over the past year, emphasized by endorsements from the National Institute for Health & Care Excellence (NICE) and multiple FDA clearances in stroke and lung fibrosis. CEO Dr. Michalis Papadakis stated, ‘We are honored to be recognized by LSX and OBN for these awards, which reflect the transformative impact our technology is having on patient care globally.’
Real-world Applications of Brainomix
In a large-scale evaluation, Brainomix 360 Stroke was found to boost the number of patients receiving mechanical thrombectomy by 50%. This procedure is crucial for treating the most severe strokes and aids in reducing long-term care needs.
The software is operational across Wales and Hungary, providing services to all stroke centers. Prof. István Szikora of the National Institute of Mental Health stated, ‘Brainomix 360 Stroke has proved itself an extremely effective asset in improving the efficacy of stroke care in Hungary.’
Future of Brainomix
As a company that originated from the University of Oxford, Brainomix continues to expand, with operations in over 30 countries. Its dedication to delivering advanced AI solutions is set to revolutionize how stroke and lung fibrosis patients receive care. To learn more, visit Brainomix.
- 0 Comments
- AI Imaging
- Awards
- Brainomix
- Healthtech
- Stroke Treatment